The Norbrook Medical Division, launched in 1999, sees the company looking towards the future and seeking further opportunities for growth. Building on existing strengths and adding new technologies, Norbrook is expanding into this area with an aggressive programme of development. Due to our on-going capital investment programme, the range of facilities at Norbrook is constantly being enhanced and we now have capacity available in several of our manufacturing areas, including our Medical Division. These facilities are designed to meet the demands of the future and combine substantial economies of scale for the largest distributor while still providing the flexibility to cater for the particular needs of specific and perhaps smaller market niches. The Norbrook ‘Quality Culture’ has ensured that approval by the world’s most rigorous regulatory systems, as well as by auditors of the major global healthcare companies is achieved on a regular basis. In the current climate of rationalisation and increasing demands on capital expenditure, Norbrook offers world class manufacturing facilities at very competitive costs and provides pharmaceutical companies a low cost, high quality alternative to investment in their own facilities. Our Company has the technology and facilities available for a wide range of products. If you would like further information on our Medical manufacturing facilities and capabilities, please do not hesitate to contact us on: Tel: +44 28 3026 4435
Fax: +44 28 3026 1721 | 
